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Abetract. Successful glaucoma filtering surgery is characterized by the passage of aqueous 
humor from the anterior chamber to the subconjunctival space, which results in the formation of 
a filtering bleb. Aqueous in the subconjunctival space may then exit by multiple pathways. Bleb 
failure most often results from fibroblast proliferation and subconjunctival fibrosis. Factors 
associated with an increased risk of bleb failure include youth, aphakia, active anterior segment 
neovascularization, inflammation, previously failed glaucoma filtering surgery, and, possibly, 
race. Several surgical and pharmacologic techniques have recently been introduced to enhance 
success in eyes with poor surgical prognoses. To elucidate the scientific rationale of these 
methods, we summarize the process of wound healing after glaucoma filtering surgery and 
describe postoperative clinical and histopathologic features, factors which may affect success, 
and specific methods to improve surgical success. (SUIT Ophthalmol 32:149-170, 1987) 
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Since de Wecker first described the “filtering cica- 
trix” as a surgical treatment for glaucoma in 1882,35 
many different filtering procedures have been per- 
formed to establish a listula between the anterior 
chamber and the subconjunctival space. Currently, 
trabeculectomy is the most popular filtering proce- 
dure;& however, full-thickness procedures such as 
posterior lip sclerectomies, thermosclerostomies, 
and trephinations are still advocated for some glau- 
coma patients.‘64 
Glaucoma filtering surgery (GFS) differs from 
most surgical procedures in that inhibition of 
wound healing is desirable to achieve surgical suc- 
cess. In recent years, several surgical and pharma- 
cologic techniques have been introduced to enhance 
GFS success. In this review, we will summarize 
wound healing after GFS and describe postoper- 
ative clinical and histopathologic features, factors 
affecting GFS success, and specific methods to im- 
prove surgical success. 
I. Clinical and Histo thologic Findings 
After Glaucoma iltering Surgery Ip” 
A. BLEB FORMATION, FAILURE, AND 
ENCAPSULATION 
Successful GFS is generally characterized by for- 
mation of a filtering bleb, which is a subconjunctival 
accumulation of aqueous. Functioning blebs may be 
thin and polycystic (Fig. 1) with transconjunctival 
flow of fluid.88 Other flatter, thicker, and more dif- 
fuse blebs with a relatively avascular appearance in 
comparison to the surrounding conjunctiva (Fig. 2) 
may also successfully lower intraocular pressure. 
Kronfeld classified the former as a Type I bleb and 
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Fig. 1. Thin, polycystic bleb following glaucoma filtering 
surgery. 
Fig. 2. Diffuse, slightly elevated bleb with relatively avas- 
cular appearance in comparison to surrounding conjunc- 
tiva. 
Fig. 3. Failed bleb (owl monkey eye) in which conjunctiva 
is scarred to underlying episclera. 
the latter as a Type II bleb.8g In failed blebs (Kron- 
feld’s Type III), the scarred conjunctiva firmly ad- 
heres to the underlying episcleral tissue (Fig. 3). 
Kronfeld’s classification did not include the en- 
capsulated bleb also known as a “Tenon’s capsule 
cyst.” ‘l’his localized, dome-shaped, cyst-like cavity 
of hypertrophied Tenon’s capsule (Fig. 4) forms 
over the filtering site, usually by the third postoper- 
ative week, and entraps aqueous, resulting in in- 
creased intraocular pressure.185 Ocular massage, 
corticosteroids, and bleb needling or surgical revi- 
sion may restore bleb function by reestablishing 
drainage of entrapped aqueous into the surrounding 
subconjunctival tissue.30J36J85 
B. HISTOPATHOLOGIC FINDINGS 
Fig. 4. Encapsulated bleb with characteristic vascular, 
dome-shaped, cyst-like appearance. 
appearance of loosely arranged connective tissue 
beneath the conjunctival epithelium in functioning 
blebs. At the light microscopic level, subepithehal 
clear spaces corresponded to conjunctival micro- 
cysts, which are seen clinically and indicate a func- 
tional filtering bleb (Figs. 5 and 6). With electron 
microscopy the loose connective tissue was observed 
to contain scattered but otherwise normal collagen 
fibrils with 50 to 200 micron channel-like spaces 
throughout the stroma. Both light and electron mi- 
croscopy showed normal conjunctival epithelium 
with no junctions between the cells that would limit 
fluid flow. Failed blebs demonstrated abnormally 
thickened, dense collagenous connective tissue be- 
neath the conjunctival epithelium, which appeared 
normal (Fig. 7). Fibroblasts and blood vessels were 
also seen within the connective tissue offailed blebs. Addicks et al’ have described a histopathologic 
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Fig. 5. Slit-lamp photograph showing microcystic spaces 
(arrows) to side of slit-lamp beam in functioning bleb. 
(Reprinted with permission from: Addicks EM, Quigley 
HA, Green WR, Robin AL: Histologic characteristics of 
filtering blebs in glaucomatous eyes. Arch Ophthalmol 
101:795-798, 1983. Copyright 1983, American Medical 
Association.) 
Fig. 6. Light micrographs correlating microcystic spaces 
(M) seen histologically with those seen clinically in Fig. 5 
(paraphenylenediamine, X 3 10). (Reprinted with per- 
mission from: Addicks EM, Quigley HA, Green WR, 
Robin AL: Histologic characteristics of filtering blebs in 
glaucomatous eyes. Arch Ophthalmol 101:795-798, 1983. 
Copyright 1983, American Medical Association.) 
Histopathoiogically, the walls of encapsulated blebs 
were thin, almost avascular membranes which con- 
sisted of sheets of fibrous connective tissue with 
areas of active proliferation of fibroblasts.‘85 The 
cyst-like spaces of encapsulated blebs were lined by 
acellular material, which was probably fibrin, and 
not by surface epithelium, which lines true cysts. 
C. AQUEOUS PATHWAYS 
Addicks et al’ proposed that subepithelial con- 
junctival microcysts represent channels for the pas- 
sage of aqueous humor, which can follow two possi- 
ble routes of egress. Aqueous can flow across the 
conjunctival epithelium into the tear film,88 or be 
directly absorbed by blood vessels in the subepithe- 
ha1 connective tissue.‘s’82 
Similar pathways were also described by Teng et 
al 18* who further suggested that direct contact with 
aqueous degraded subconjunctival and episcleral 
collagen fibers and contributed to the production of 
thin multicystic blebs. ‘** Teng et al also theorized 
that aqueous may cause “loose perivascular degen- 
eration” of episcleral and subconjunctival capillar- 
ies, which may facilitate filtration by increasing 
aqueous absorption directly through the blood ves- 
sel wall. 
Another possible aqueous outflow pathway was 
identified in which the proliferating endothelium of 
cut capillaries contributed to the formation of anas- 
tomotic channels which could communicate directly 
with the deep scleral venous plexus.“’ This mecha- 
Fig. 7. Histologic appearance of failed bleb. Capillaries 
(C) present in subepithelial dense collagenous connective 
tissue (paraphenylenediamine, X 530). (Reprinted with 
permission from: Addicks EM, Quigley HA, Green WR, 
Robin AL: Histologic characteristics of filtering blebs in 
glaucomatous eyes. Arch Ophthalmol 101:795-798, 1983. 
Copyright 1983, American Medical Association.) 
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nism may explain postoperative intraocular pres- 
sure control without a visible bleb. Other explana- 
tions for intraocular pressure control in the absence 
of a bleb include an inadvertent cyclodialysis 
cleft’43J57 or aqueous outflow through the conjuncti- 
val lymphatic system.‘3J4 
Direct aqueous flow through the cut ends of 
Schlemm’s canal was originally theorized as the 
mechanism by which trabeculectomy reduced intra- 
ocular pressure, *26 however, histologic findings do 
not support this route. ‘43~‘73 The primary mechanism 
by which trabeculectomy lowers intraocular pres- 
sure is subconjunctival filtration. Whether aqueous 
passes through the partial thickness scleral flap,16’ 
around the margins of the scleral flap,13 or both 
remains unclear. Possible aqueous pathways after 
trabeculectomy are summarized in Fig. 8. 
II. Animal Models of Glaucoma Filtering 
Surgery 
Clinical and histopathologic observations in hu- 
mans have contributed to our understanding of 
functional and nonfunctional blebs. Because the 
early events of GFS wound healing have not been 
well described in humans, animal models have been 
used to delineate the initial stages of wound healing. 
A. RABBITS 
Seetner and Morin described bleb formation after 
trabeculectomies in rabbits in the first few postoper- 
ative days.‘58 All blebs uniformly failed in 10-14 
days. Histopathologically, fibrin clots were seen in 
the area of the trabeculectomy after two days. Fi- 
broblastic proliferation, first noted after five days, 
proceeded to completely fill the trabeculectomy site 
with libroblasts and newly formed collagen by the 
fourteenth postoperative day. The subconjunctival 
tissue was thickened on the fourteenth postoper- 
ative day, and cellular proliferation and new blood 
vessels were noted. By 30 days after surgery, the 
subconjunctival tissue was approaching normal 
thickness, little cellular proliferation was noted, and 
a dense collagenous scar was present. Miller et al 
performed thermosclerostomies in rabbits and simi- 
larly reported occlusion of the sclerostomies with 
fibrous tissue by the tenth postoperative day.‘17 
These findings confirm previous observations in 
rabbits which had undergone trephinations.40gg’ 
Rabbit eyes are poorly suited anatomically for use 
as GFS models. The ciliary processes are attached 
to the posterior surface of the iris to within 1 mm of 
the pupillary edge. ‘37,‘38~‘52 Thus, iridectomy pro- 
duces hemorrhage’17 as well as destruction of the 
underlying ciliary processes.‘52 In addition, many of 
the zonular fibers of the large rabbit lens are insert- 
ed onto the anteriorly located ciliary processes.‘3g 
Fig. 8. Possible aqueous pathways after trabeculectomy 
include passage: (1) into cut ends of Schlemm’s canal (not 
supported by histopathologic findings); (2) into intca- 
scleral outflow channels or through thinned scleral lamel- 
lae; (3) around margins of scleral flap; and/or (4) into 
cyclodialysis cleft created during surgery. Aqueous that 
enters subconjunctival space may exit transconjunctival- 
ly or through absorption by blood vessels and/or conjunc- 
tival lymphatic system. (Reprinted with permission from: 
Spencer WH: Histologic evaluation of microsurgical 
glaucoma techniques. Tram Am Acad Ophthalmol Otolayz- 
go1 76:38%397, 1972.) 
B. DOGS AND CATS 
Glaucoma filtering surgery in the eyes of dogslw 
and cats14* has also been described. Because the iris 
is highly vascular and the major arterial arcade is 
present at the peripheral iris in both dogs’06,‘75 and 
cats,‘07 severe anterior chamber hemorrhage may 
occur during iridectomy.‘06J75 
C. MONKEYS 
The anterior chamber anatomy of nonhuman pri- 
mates is similar to that of humans” and is well 
suited for study of GFS. Regan performed posterior 
lip sclerectomies and thermosclerostomies in mon- 
keys and reported surgical success only with the 
latter procedure. 14* Posterior lip sclerectomies were 
first filled by loose connective tissue followed by 
closely packed fibrous connective tissue secondary 
to fibroblast proliferation. In thermosclerostomies, 
obliteration of the drainage channel occurred if 
cautery was not applied to at least two-thirds the 
depth of the incision. The success was attributed to 
the cautery effects which produced scleral shrink- 
age, inhibition of neovascularization, and decreased 
fibroblastic proliferation necessary for wound 
healing.‘42J87 
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Desjardins et al also performed posterior lip scler- 
ectomies in owl monkeys.34 They described three 
clinicohistopathologic phases of wound healing. In 
the first six days after surgery (early healing), the 
limbal fistulas generally remained open, although 
by day six, fibroblasts had begun to proliferate 
along the walls of the opening. Fibrinous material at 
the limbal fistula was seen in at least one eye early in 
the postoperative period. During the intermediate 
healing phase (days 7-9), continued proliferation 
and migration of fibroblasts, which were pre- 
sumably derived from the adjacent episclera and 
subconjunctival tissue, were observed. Fibroblasts 
during the intermediate stage were predominantly 
oriented perpendicular to the corneoscleral 
lamellae. In the late healing phase (days lO-14), the 
limbal fistulas, with one exception, were completely 
closed by granulation tissue. The fibroblasts were 
oriented in a plane parallel to the cornea, a finding 
consistent with early wound remodeling and 
maturation. 
In additional studies of the wound healing proc- 
ess after posterior lip sclerectomies in primates, 
Goodman et aP4 noted initial plugging of the fistula 
with a fibrin/cellular clot (days l-4). During days 
7-14, ingrowth of episcleral fibroblasts, migration 
of macrophages, blood vessel formation, and de- 
position of collagen were noted. As previously re- 
ported, 34 complete closure of the fistula occurred 
by day 14.54 
A similar healing response was documented by 
Jampel et al, who utilized electron microscopy, im- 
munohistochemical methods, and autoradiographic 
studies in addition to light microscopy.78 Autoradio- 
graphic techniques demonstrated cellular prolifera- 
tion along the edges of the wound, in the conjuncti- 
val substantia propria, and in the cells lining 
episcleral blood vessels. 
III. Sequence of Events in Wound 
Healing 
Although recent studies have documented the 
early events of wound healing after GFS, our knowl- 
edge remains incomplete. In the context of general 
wound healing,3g,‘32 observations in animal mod- 
els 34~54*78~1’7~‘42~‘58 and after GFS in humans1,‘82 suggest 
a sequence of events in GFS wound healing that 
occurs in early bleb failure. After surgical trauma to 
the conjunctiva, episclera, and iris, blood vessels 
constrict, and leakage of plasma proteins (including 
fibrinogen, fibronectin, and plasminogen) and 
blood cells occurs.3g,96 When exposed to tissue fac- 
tors,5 plasma, or blood, or both clot to form a gel-like 
fibrin-fibronectin matrix, into which inflammatory 
cells (including monocytes and macrophages), new 
capillaries, and fibroblasts migrate.34,3g,54,78,‘58 Rabbit 
Events of Wound Healing In GFS Failure 
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Fig. 9. Diagram of major stages of wound healing in early 
bleb failure after glaucoma filtering surgery. 
and monkey studies indicate that fibroblast prolif- 
eration and migration after GFS begins around the 
fifth postoperative day34,Ls8 and that the fibroblasts 
are derived from the edges of the wound, the sub- 
conjunctival tissue, and the episcleral tissue.34,78 
The fibrin-fibronectin matrix is eventually de- 
graded by inflammatory cells,3g and fibroblasts sub- 
sequently synthesize fibronectin, interstitial col- 
lagens, and glycosaminoglycans to form young 
fibrovascular connective tissue, also known as 
granulation tissue. 34,3g Blood vessels are reabsorbed 
over time and fibroblasts largely disappear as the 
tissue is remodeled to form a dense collagenous sub- 
conjunctival scar with scattered fibroblasts and 
blood vessels.‘s3’ The events of wound healing in 
early GFS failure are summarized in Fig. 9. 
Fibroblast proliferation and migration play 
prominent roles in GFS wound healing.34,54,78.‘58 Pre- 
cisely which tissue factors are most important in the 
activation of fibroblasts after GFS is not known. 
What is known, however, is that a large number of 
factors appear to be chemotactic for fibroblasts in 
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general. 3g These include lymphokines, complement, 
native collagens of types I to V, fibronectin, some 
proteolytic digestion fragments of collagen and fi- 
bronectin, and platelet-derived growth factor. The 
latter is a particularly potent mitogen and chemoat- 
tractant for fibroblasts.3g~g7~‘5’~1g7 Future investiga- 
tions may identify which of these factors play crucial 
roles in determining bleb failure. 
IV. Anatomical and Ph 
Factors Related to Ble g 
siological 
Failure 
A. EXTERNAL FACTORS 
External factors at the episceral-conjunctival in- 
terface are responsible for most cases of GFS fail- 
ure.‘J’2 In 1960 Maumenee proposed that the most 
likely cause of initial malfunction after filtering sur- 
gery was the failure of Tenon’s capsule or subcon- 
junctival tissue to absorb aqueous.‘08 He later ob- 
served, however, that “in patients in whom 
filtration is destined to fail, even excision of most of 
the subconjunctival tissue will not prevent an im- 
permeable layer of connective tissue from sealing off 
the wound in the first few postoperative days.“‘Og 
Most observers now agree that fibroblast prolifera- 
tion, synthesis of the extracellular matrix (collagen 
and glycosaminoglycans), and subsequent develop- 
ment of subconjunctival fibrosis play prominent 
roles in external failure.‘,34,78J58 Addicks et al have 
also emphasized the possible role of synthesis of the 
extracellular matrix.’ 
B. INTRAOCULAR AND SCLERAL FACTORS 
While the extraocular factors cited above are re- 
garded as the primary cause of failure of GFS, intra- 
ocular and scleral factors have also been cited as 
potential causes of failure.‘@g’m Intraocular compli- 
cations can lead to blockage of the filtration site by 
prolapse of lens, iris, vitreous, or ciliary body. An 
inadequate opening into the anterior chamber due 
to scleral remnants or Descemet’s membrane in the 
fistula may also lead to primary failure. Many of 
these potential causes of bleb failure can be avoided 
by careful surgical technique. Performance of a bas- 
al iridectomy, anterior vitrectomy when indicated, 
and adequate removal of the sclerectomy specimen 
can enhance the likelihood of a patent fistula. 
C. INFLAMMATION AND BLOOD 
Intense preoperative and postoperative inflam- 
mation is undesirable*Jog because of the associated 
fibrinous and cellular responses and accelerated 
wound healing. Indeed, GFS success in patients 
with the uveitic glaucomas is generally poor.4’,74 
Clinical observations suggest that the presence of 
blood beneath the conjunctival flap postoperatively 
may also increase the probability of bleb failure463164 
though the specific effects of subconjunctival blood 
on wound healing have not been studied. As noted 
above, serum derivatives including fibronectin and 
platelet-derived growth factor may stimulate fibro- 
blast migration and proliferation.g7Jg7 In addition, 
macrophages, which may be activated ,by blood, 
appear to play a key role in inducing the fibroprolif- 
erative response in epiretinal membrane forma- 
tion’16 and wound repair in genera1.3g,96J50 Extrapo- 
lation of these observations to GFS wound healing is 
consistent with the clinical impression that the pres- 
ence of blood increases the likelihood of postoper- 
ative fibrosis. 
V. Clinical Factors Associated with Bleb 
Failure 
Kolker and Hetherington estimate an 8&90% 
success rate in glaucoma filtering surgery for prima- 
ry open angle glaucoma (POAG) .85 Success rates of 
67% to 94% in the primary glaucomas (POAG and 
chronic angle closure glaucoma) have been report- 
ed ‘1g~‘45~‘46~‘56~‘57~‘76~‘88 Youth, aphakia, active anterior 
segment neovascularization, previously failed GFS, 
and, possibly, race are risk factors associated with 
GFS failure. 
A. YOUTH 
Beauchamp and Parks reported 50% success in 
controlling intraocular pressure (11 of 22 eyes; IOP 
124 mm Hg; mean follow-up 18 months) in chil- 
dren after trabeculectomy.g A similar 52% success 
rate with trabeculectomy and thermosclerostomy in 
childhood glaucoma was described by Cadera et al 
(20 of 38 eyes; IOP <22 mm Hg with or without 
medications; mean follow-up 50 months), although 
five of the 20 successes had required a second filter- 
ing procedure. 25 All patients in these two series were 
under age 20 years. 
In a series of trabeculectomies in patients under 
age 50, Gressel et al reported success rates (IOP 
121 mm Hg with or without medications or 22-25 
mm Hg without medications) of 35% in the devel- 
opmental glaucomas (6 of 17 eyes with mesodermal 
dysgenesis, Sturge-Weber syndrome, congenital ru- 
bella, primary infantile glaucoma, aniridia, or mi- 
crocornea with congenital cataract) and 48% in the 
secondary glaucomas (24 of 50 eyes, most of which 
had trauma-associated glaucoma, inflammatory 
glaucoma, or previous ocular surgery) .56 Trabecu- 
lectomies in patients age 30 to 49 with primary open 
angle glaucoma or chronic angle closure glaucoma 
resulted in 83% success (25 of 30 eyes), and were 
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TABLE 1 
Series of Trabeculectomy in Aphakic Eyes 
Follow-up 
Age (years) 
Authors Success Rate Success Criteria (months) Range Mean 
Schwartz and Anderson15s 4/12*7 (33%) IOPs20 mm Hg 24 27-82 60.4 
Mehta et a1ir3 16/23* (70%) IOPs21 mm Hg O-16 - - 
Herschler et a163 12 5-95 47 
Singh and Singh’@j 
12/31* (39%) IOPs20 mm Hg 
35/40* (88%) IOPs20 mm Hg >g - - 
Herschler66 21/28t§ (75%) IOPs21 mm Hg 26 19-80# 61# 
Sharma and Singh’5g 23/25* (92%) IOP<22 mm Hg ?2 50-80 - 
Bellows and Johnstone12 12/20*t (60%) 
Heuer et aPg 
IOPs21 mm Hg 2.5 15-83 61.4 
32/82* (39%) IOPs21 mm Hg with meds 26 G-83 59.1 
IOPs25 mm Hg without meds 
IOP = Intraocular pressure. 
*All cases were trabeculectomies. 
tExcluding reoperations and cases of neovascular glaucoma. 
370% of 47 cases in overall series were trabeculectomies. 
#Age range and mean for overall series of 41 patients. 
-Not specified. 
(Modified from Heuer DK, Gressel MG, Parrish RK II, et al: Trabeculectomy in aphakic eyes. Ophthalmol- 
ogy 91:1045-1051, 1984). 
considerably more successful than in the small num- 
ber of patients with the primary glaucomas below 
age 30 (44% success rate in four of nine eyes.) 
Poor success rates in young patients have been 
attributed in part to previous ocular surgery, the 
thickness of Tenon’s capsule, and a more vigorous 
healing response in youth.g To our knowledge, the 
rate of ocular wound healing as determined by age 
has not been specifically evaluated. However, stud- 
ies of wound healing in rats73J7* and in vitro collagen 
biosynthesis by human skinla4 support the concept 
of a more vigorous healing response in youth. 
Holm-Pederson et al studied incisional skin 
wounds in young (2-3 months) and old (20-26 
months) male rats and found delayed vascular pro- ’ 
liferation and decreased early inflammation in older 
animals as compared to younger animals.73 Similar- 
ly, Sussman demonstrated that skin wounds in older 
rats synthesized less fibrous connective tissue than 
younger rats. ‘78 Uitto reported a continual decrease 
in the amount of in vitro collagen synthesis by hu- 
man skin from infancy up to age 30 to 35, after 
which the rate remained essentially unchanged.‘84 
The latter finding is of particular interest in rela- 
tion to the observation of Gressel et al that patients 
over age 30 with the primary glaucomas demon- 
strated a success rate similar to those reported in 
older age groups ? This suggests that, in the ab- 
sence of additional confounding factors, the vigor of 
the healing response in young patients may be less 
important after a particular age. 
B. APHAIUA 
Reported success rates of GFS in aphakia vary 
from 33% to 92% though most large series report 
distinctly diminished success rates (Table 
1). ‘2~63~66,6g~“3~‘56~‘5g~‘66 In the largest series by Heuer et 
al (82 eyes), a 39% overall success rate was report- 
ed, including a 5% success rate in patients under 
age 50.6g 
It is not completely understood why trabeculecto- 
mies so frequently fail in aphakic eyes. Heuer et al 
speculate that previous conjunctival scarring at the 
operative site may unfavorably influence the surgi- 
cal outcome. However, Herschler has stated that 
selection of unscarred conjunctiva for GFS after lens 
extraction did not increase the surgical success.66,67 
Vitreous incarceration into the filtering site has 
been described as a cause of bleb failure in aphakic 
eyes,‘08,“J9,‘56 alth ough Herschler et al observed that 
such vitreous incarceration was not necessarily as- 
sociated with failure of liltration.63 He offered an 
alternative hypothesis that the primary cause of 
GFS failure in aphakic eyes was related to biological 
alteration of the aqueous by a fibroblast stimulant 
released from the vitreous and that removal of the 
vitreous would therefore increase surgical success.66 
In support of this hypothesis, he reported 75% suc- 
cess (IOP 5 2 1 mm Hg; follow-up 2 6 months) after 
one filtering procedure in 28 nonneovascular apha- 
kit eyes that underwent total vitrectomy either prior 
to or combined with GFS.‘j” 
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Authors 
TABLE 2 
Series of Glaucoma Filtering Surgery in Blacks 
Procedure Success Rate Success Criteria 
Follow-up Age (years) 
(months) Range Mean 
Bakker and Manku6 T 3 l/39 (80%) IOP<22 mm Hg 
s 29139 (74%) IOP<22 mm Hg 
T 40147 (85%) IOP<22 mm Hg 
David et a133 T 36/49 (73%) IOP<20 mm Hg 
Welshlg* T 19/29 (65%) IOP<20 mm Hg 
Miller and Barberlla 
T(23),S;4)>P(9) 
70/122 (57%) IOP<21 mm Hg 
MerrittIt 8136 (22%) IOP<22 mm Hg 
Ferguson and Macdonald43 T 42/50 (84%) IOP121 mm Hg 
Freedman et a145 T 53164 (82%) IOP<20 mm Hg 
Thommy and Bhar1a3 T 106/l 11 (95%) IOPs20 mm Hg 
Kietzmana3 T 1641221 (74%) IOP120 mm Hg 
P 165/196 (84%) 
Sandford-Smith153 T 33/51 (65%) IOP120 mm Hg 
P 16/27 (60%) 
Ben Sira and Ticho”j 25/27 (93%) IOP<18 mm Hg 
Ben Ezra and Chirambo15 ; 79/100 (79%) _IOP<21 mm Hg 
Schimek and Williamson’54 T 19/23 (83%) IOP<20 mm Hg 
T = Trabeculectomy. 
S = Scheie procedure (Thermosclerostomy). 
P = Posterior lip sclerectomy 
+ = 9 Lagrange sclerotomies, 6 Scheie procedures, 12 Elliot trephinations. 
* = Age range and mean for overall series, not just blacks. 
- = Not specified. 
>3 20-75 55.4 
>3 25-73 51.7 
>6 35-75 - 
>3 - - 
212 O-80 52.3 
26 27-76 57.2 
224 40-78 58.5 
19 - 56.8 
=6 36-62 - 
24 - - 
23 - - 
26 - 36 
2-12 >50 - 
>6 48-83* 66.4* 
More recent studies also suggest that vitreous 
may stimulate fibroblast proliferation.‘86Jg3 Wiede- 
mann et al have shown that bovine vitreous stimu- 
lated the proliferation of dermal fibroblasts in tissue 
culture.tg3 They believe that the active substance 
responsible for fibroblast proliferation is a noncol- 
lagenous protein with a molecular weight of about 
14000 MW. If a vitreous factor is responsible for 
fibroblast proliferation and surgical failure in apha- 
kit glaucoma, improved success may be expected in 
patients with intact posterior capsules. However, 
the validity of this expectation has not yet been 
carefully determined. 
C. ANTERIOR SEGMENT 
NEOVASCULARIZATION 
The likelihood of GFS success in neovascular 
glaucoma is poor. Heuer, for example, reported only 
11% success in initial filtering procedures for neo- 
vascular glaucoma in 36 eyes.70 This poor prognosis 
may be explained in part by intraoperative hemor- 
rhage during conjunctival dissection and iridec- 
tomy, which may subsequently stimulate postoper- 
ative scarring. &,16* Eyes with neovascular glaucoma 
often demonstrate marked inflammation preoper- 
atively as well as postoperatively. This too may pro- 
vide a framework for accelerated wound healing. 
Breakdown of the blood-aqueous barrier and the 
associated leakage of serum proteins may provide 
an additional stimulus for libroblast proliferation.‘40 
In addition, fibrovascular proliferation from the iris 
at the site of the internal sclerectomy may contrib- 
ute to surgical failure. 
To minimize intraocular hemorrhage, Herschler 
recommended a modified filtering operation for 
neovascular glaucoma in which focal cauterization 
was applied to the iris and ciliary processes.64J31 By 
Heuer’s criteria, this method achieved a 33% suc- 
cess rate. Allen et al reported 67% success (IOP 
120 mm Hg or 126 mm Hg and stable optic 
nerves) in 24 eyes with neovascular glaucoma and 
emphasized the importance of preoperative panret- 
inal photocoagulation, preoperative treatment of in- 
flammation, and attention to intraoperative hemo- 
stasis as factors contributing to their higher success 
rate.3 
D. PREVIOUSLY FAILED GLAUCOMA 
FILTERING SURGERY 
Failed GFS may be associated with a decreased 
rate of success in subsequent procedures. Although 
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the reasons for this association are not known, an 
inherently greater healing response in some pa- 
tients, operating in the site of previous surgery, and 
increased inflammation with repeat surgeries could 
be contributing factors.‘56 
Kolker and Hetherington estimated at least a 
50% success rate of repeat filtering procedures,86 
but Schwartz and Anderson reported success (IOP 
5 20 mm Hg with or without medications; follow-up 
I 4 months) in only four of ten eyes with previously 
failed GFS.15+j Inaba calculated an overall five-year 
64% failure probability (36% success) with a life 
table method in 76 eyes (success: IOP < 21 mm Hg 
with or without medications) after repeat trabecu- 
lectomies in Japan.77 Thirty-two of the eyes were in 
patients with congenital glaucoma, for which the 
failure probability after two or more surgical in- 
terventions was 80% (20% success). In a separate 
analysis in which eyes with congenital glacuoma 
were excluded, a 49% failure probability (51% 
success) after repeat trabeculectomies in 19 eyes 
with primary open angle glaucoma (POAG) and a 
53% failure probability (47% success) in 17 eyes 
with primary angle closure glaucoma (PACG) were 
reported. 
The failure probabilities were higher after repeat 
trabecuiectomies than after single trabeculectomies 
in POAG (40%, 132 eyes) and PACG (48%, 130 
eyes) ,” although these differences were less than 
might be expected. Many more patients in the single 
and repeat trabeculectomy groups would be needed 
to statistically differentiate their success rates. Per- 
haps the general impression that repeated filtering 
procedures do not fare as well is due to a dispropor- 
tionate percentage of eyes with poor progress, e.g., 
congenital glaucoma, among those eyes undergoing 
such procedures. 
E. RACE 
The clinical impression that GFS failure in blacks 
is more likely to occur is widely held.‘7,75,‘15 and has 
been attributed in part to an exuberant healing re- 
sponse exemplified by frequent hypertrophic scar 
(keloid) formation. %,“O However, several recent se- 
ries have indicated surgical success rates of 73% to 
95% (Table 2) .6,15,‘6.33,43,45,83,‘54.183 Although Miller 
and Barber reported overall success (IOP d 2 1 mm 
Hg with medications or I25 mm Hg without medi- 
cations; follow-up >6 months) in only 57% of 
blacks after trabeculectomy, the operation was suc- 
cessful in 82% of blacks over age 60.“” Whether 
race, independent of age, is a risk factor for bleb 
failure remains unsettled though the cited studies 
suggest that the surgical prognosis in blacks may be 
better than previously believed. 
VI. Aqueous Humor Effects That May 
Enhance Bleb Formation 
A. DIRECT EFFECTS 
Several investigators have emphasized the possi- 
ble role of aqueous humor in bleb formation. Teng 
et al suggested that aqueous may have deleterious 
effects on mature collagen, but were unable to deter- 
mine whether these effects were due to hydrolysis, 
solubilization, or enzyme action.la2 They noted that 
if connective tissue at the surgical site was covered 
by endothelium, no degenerative effects were 
produced. In an animal model of GFS, Regan de- 
scribed scleral degeneration and “spongy” connec- 
tive tissue in areas not covered by this singular layer 
of cells, which was presumably derived from the 
cornea1 endothelium.‘42 
To investigate the effects of aqueous on connec- 
tive tissue, Chi et al placed autologous scleral im- 
plants into the anterior chambers of rabbit eyeszg 
Most implants were encapsulated by endothelial- 
like cells and remained unchanged. The nonencap- 
sulated implants underwent a decrease in cellular- 
ity, a loss of ground substance, and eventual 
disintegration of the collagen fibers. 
Recent electron microscopic investigations docu- 
mented that normal appearing collagen fibrils with 
a typical banding pattern were present in both func- 
tioning and failed blebs.’ A lack of specific collagen 
fibril abnormalities or other degenerative changes 
in filtering blebs have led Addicks et al to doubt the 
existence of a direct aqueous effect on collagen as an 
important factor in bleb formation. 
B. EFFECTS ON FIBROBLASTS 
Teng et al proposed that aqueous may inhibit 
collagen production by fibroblasts.‘*’ Others had 
reported that surgica1,32~62~“0 traumatic,“’ and ther- 
ma1’6g iris wounds did not scar. While this observa- 
tion may be partly due to mechanical separation of 
tissue,‘* Snell speculated that aqueous may have an 
inhibitory effect on fibrosis.‘6g Inhibition of fibro- 
blast proliferation by aqueous humor added to the 
nutrient medium in tissue culture has been reported 
with chick embryo fibroblasts, rabbit mesentery fi- 
broblasts and rabbit iris.87 
Herschler et al noted that primary aqueous ob- 
tained before surgery from 19 of 19 cataract patients 
and from 29 of 45 glaucoma patients inhibited the 
proliferation of the patients’ own subconjunctival 
fibroblasts in tissue culture.65 He also described a 
significant positive correlation (p < .Ol , Wilcoxon 
two sample rank test) between successful filtering 
surgery and the inhibitory effect of 100% human 
aqueous on autologous fibroblasts in tissue culture. 
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Despite this positive correlation, interpretation may 
be confounded by (1) difficulty in disinguishing be- 
tween a true inhibitory effect and a lack of sufficient 
nutrients; (2) the variability in the types of glauco- 
ma patients included in the study (22 with POAG, 
nine with neovascular glaucoma, nine with aphakic 
glaucoma, one with uveitic glaucoma, and four with 
angle closure glaucoma); and (3) the inability to 
control for preoperative medications. Herschler not- 
ed that filtering blebs were maintained in some pa- 
tients whose aqueous humor supported libroblast 
proliferation and not in others whose aqueous did 
not support proliferation.65 Since preoperatively 
sampled aqueous (primary aqueous) had been used 
in this study, Herschler suggested that the effect of 
postoperative aqueous may be more important with 
respect to the ultimate success of GFS. 
To test this hypothesis, Radius et al sampled 
aqueous before and after GFS in monkeys and found 
that initiation of monkey subconjunctival fibroblast 
proliferation in tissue culture was inhibited by pri- 
mary aqueous humor but supported by postoper- 
ative aqueous. I40 They offered two possible explana- 
tions for these findings: (1) primary aqueous humor 
lacks sufficient nutrient material, such as serum fac- 
tors, to support fibroblast growth; and (2) factors 
present in postoperative aqueous inactivate the in- 
hibitors of fibroblast proliferation that are normally 
present in the primary aqueous humor. 
Addicks et al attributed these observations to the 
lack of appropriate nutrients in normal aqueous hu- 
mor and release of plasma protein nutrients in post- 
operative aqueous resulting from breakdown of the 
blood-aqueous barrier. ’ Since no specific aqueous 
antifibroblast substance has been isolated and 
aqueous under some conditions may stimulate fi- 
broblast replication, 2~140 further investigation to bet- 
ter determine the influence of aqueous biology and 
composition on GFS success is needed. 
VII. Clinical Factors That May Enhance 
Bleb Formation 
A. SURGICAL TECHNIQUE 
1. Preoperative, Intraoperative, and 
Postoperative Care 
Speculation that changes in surgical techniques 
may increase success has led to a variety of modifi- 
cations. It is not our purpose to review all recent 
surgical variations in GFS; however, we wish to 
emphasize the importance of the general principles 
of preoperative, operative, and postoperative care 
that may reduce postoperative scarring. Preoper- 
ative inflammation should be treated with antiin- 
flammatory agents, usually corticosteroids, and 
TABLE 3 
Complications of Glaucoma Fi1terin.g Surzeery 
Trabecul- Thermo- 
ectomy sclerostomy 
(n = 48) (n = 50) 
Early Postoperative 
Flat anterior chamber 
Shallow anterior chamber 
Late Postoperative 






Hypotony, 10 mm Hg 
1 year 
2 years 


















Modified from Blondeau P, Phelps CD: Trabeculectomy 
vs thermosclerostomy; A randomized prospective clinical 
trial. Arch Ophthalmol 99:810-816, 1981 (Copyright 1981, 
American Medical Association). 
miotics such as echothiophate iodide, which breaks 
down the blood-aqueous barrier,‘@ should be dis- 
continued at least two weeks before GFS. Postoper- 
ative treatment of inflammation with topical and 
sometimes systemic corticosteroids and cycloplegic 
agents, usually atropine, is also important. Cyclo- 
plegic agents help restore the blood-aqueous bar- 
rier5g and may reduce the release of plasma proteins, 
which may contribute to the postoperative healing 
response. 3g With respect to surgical technique, tis- 
sue trauma should be minimized and unnecessary 
manipulation of the conjunctiva and iris avoided. 
Meticulous hemostasis should be performed to de- 
crease bleeding under the conjunctival flap. Remov- 
al of the inner sclerectomy block should establish a 
patent channel without remnants of Descemet’s 
membrane. A basal iridectomy prevents postoper- 
ative iris incarceration at the filtering site. An ante- 
rior vitrectomy should be performed when postop- 
erative vitreous could potentially obstruct the 
filtering site. 
2. Full-thickness Versus Partial-Thickness 
Procedures 
The surgical results and complications after full- 
thickness procedures and trabeculectomies repre- 
sent an important clinical issue with implications on 
the wound healing response. In a prospective ran- 
domized clinical trial comparing trabeculectomy 
(48 eyes) to thermosclerostomy (50 eyes), Blondeau 
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TABLE 4 
Series Comparing Trabcculectomy to Full Thickness Procedures 
Post-op IOP Follow-up 
Age (years) 
Authors Procedure Success Rate (mm Hg) Success Criteria (months) Range Mean 
Blondeau and Phelps’* T 34142 (81%) 17.1 <22 mm Hg 12 - 59.3 
s 40/44 (91%) 13.9 <22 mm Hg 12 - 60.1 
T 32137 (86%) 15.9 <22 mm Hg 24 - 59.3 
s 32/35 (91%) 13.0 <22 mm Hg 24 - 60.1 
Lewis and Phelpsg* T 35137 (95%) 16.2 <22 mm Hg 60 - 58.6 
S 31/34 (91%) 15.7 <22 mm Hg 60 - 60.0 
Shieldsl’j’ T 21/26 (81%) 15 521 mm Hg 20 6-74 38 
P 20/23 (87%) 14 121 mm Hg 12 6-81 46 
Drance and Vargas37 T 33/36 (92%) - <20 mm Hg 36 - - 
S 18/22 (82%) - <20 mm Hg 36 - - 
Schwartz PL et a1’57 T 25127 (93%) - <20 mm Hg 20 eyes26 31-82 59.7 
P or Treph 17/22 (77%) - <20 mm Hg 19 eyes26 48-72 61.0 
s tx* c tx** 
Spaeth171J72 T IO/13 (77%) 22.2 17.1 “Control of glaucoma” 260 15-80 - 
S 12/13 (92%) 16.5 13.5 “Control of glaucoma” 260 15-80 - 
Spaeth170 T 16/22 (73%) 16.6 “Control of glaucoma” 36 - 59.7 
23127 (85%) 12.3 “Control of glaucoma” 36 - 53.4 
Watkins and Brubaker’8g t --I49 17 - 212 15-80 62+ 
Treph --I27 15 - 212 3G-85 65+ 
T = Trabeculectomy. 
S = Scheie procedure (Thermosclerostomy), 
P = Posterior lip sclerectomy. 
Treph = Trephination. 
* = Without medications. 
** = With medications. 
+ = Median age. 
- = Not specified. 
and Phelps reported that thermosclerostomy low- 
ered IOP approximately 3 mm Hg more than tra- 
beculectomy (average follow-up 2.7 years) .I8 How- 
ever, the percentage of eyes with intraocular pres- 
sures less than 22 mm Hg was not significantly 
different for the two operations. Postoperative com- 
plications such as flat anterior chamber, decrease in 
visual acuity, cataract, hypotony, and thin bleb 
with late infection or perforation occurred more fre- 
quently after thermosclerostomy (Table 3). Similar 
findings have been reported by others (Table 
4). 37~g8~‘6’~‘70~‘7’~‘72~‘8g In short, successful trabecu- 
lectomy appears to decrease the incidence of post- 
operative complications but produces thicker more 
diffuse blebs and slightly higher postoperative intra- 
ocular pressures than full-thickness procedures. 
3. Excision of Tenon’s Capsule 
The effect of the excision of Tenon’s capsule on 
GFS success is questionable. Welsh suggested that 
Tenon’s capsule reacts to surgical trauma and pro- 
vides fibroblasts, which close sclerostomies with fi- 
brous tissue.‘g0 Kietzman83 and Ben Sira and Ticho”j 
attributed their 74-93% GFS success rates in blacks 
to removal of Tenon’s capsule. In contrast, Gorin 
reported 82% success by creating conjunctival flaps 
in which he dissected conjunctiva from Tenon’s 
capsule to avoid extensive manipulation of Tenon’s 
capsule.55 Maumenee, who initially theorized that 
bleb failure resulted from the inability of Tenon’s 
capsule or the subconjunctival tissue to absorb 
aqueous, ‘08 later concluded that excision of subcon- 
junctival tissue did not enhance the surgical success 
rate but did produce thinner blebs when success- 
fu1.‘09 Comparing trabeculectomy with or without 
tenonectomy, Kapetansky failed to establish a sig- 
nificant difference in postoperative IOPs in the two 
groups of patients.80 
4. Fomix-Versus Limbus-based Flap 
Although a fornix-based conjunctival flap’o’J63 
might prevent scarring of the posterior conjunctiva 
and Tenon’s capsule, randomized studies of limbus- 
versus fornix-based conjunctival flaps in primary 
trabeculectomies failed to document significant dif- 
ferences in surgical success between the two techni- 
ques.‘63,‘83a The final appearance of the filtration 
blebs was similar and independent of the type of 
conjunctival flap, although Traverso et al noted a 
tendency toward more anteriorly positioned blebs 
early in the postoperative period with fornix-based 
flaps.‘83a Shuster et al speculated that the technical 
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and theoretical advantages of the fornix-blased flap 
may be more important in glaucomas associated 
with youth, aphakia, uveitis, and previously operat- 
ed conjunctiva. ‘63 The validity of this speculation 
has not been proven. 
5. Beta Radiation 
The potential value of beta radiation to inhibit 
fibroblast proliferation in eyes at increased risk for 
postoperative scarring has been reported. Iliff, who 
believed that blacks were at increased risk for post- 
operative failure, recommended postoperative irra- 
diation to the surgical site.75 He initially reported 
that beta radiation increased success in 8 of 11 
blacks,75 but later concluded that beta radiation did 
not substantially alter postoperative fibrosis.76 
Successful filtration in eight of ten blacks was 
described by Cohen et al, who applied beta radi- 
ation after completion of surgery and one week and 
two weeks postoperatively.3’ Friedenwalde also re- 
ported increased surgical success with postoperative 
radiation in eyes with a history ofprevious intraocu- 
lar surgery, recent uveitis, postoperative hemor- 
rhage in the anterior chamber or under the bleb, 
and essential iris atrophy.& Successful use of 
2200-5000 rad doses of beta radiation in eyes with 
previously failed surgery or neovascular glaucoma 
has been described by Cameron.*’ 
Although beta radiation as an adjunctive therapy 
is not widely employed, some recent studies reflect 
renewed interest in its effects. In tissue culture, Ne- 
varez et al have shown that 285 rads from a stron- 
tium 90 applicator and 300 rads from a linear accel- 
erator decreased owl monkey Tenon’s libroblast 
proliferation after three days to 45% and 43%, re- 
spectively, compared to controls.‘*’ A dose of 1000 
rads with the linear accelerator achieved an addi- 
tional antiproliferative effect (36% of control) al- 
though 3000 rads did not reduce fibroblast prolif- 
eration any more than 1000 rads. When measured 
seven days after treatment with 300, 1000, and 3000 
rads from the linear accelerator, libroblast prolifera- 
tion was reduced to 44%, 14%, and 14% of control 
values. 
In a similar study, Friedman et al reported that 
single doses of beta irradiation as low as 500 rads 
were cytotoxic to cultured conjunctival fibro- 
blasts.47~48 They also assessed the postirradiation in- 
flammatory response of normal rabbit conjunctiva 
to 2500 rad doses from a strontium 90 source and 
reported no significant difference in the appearance 
of irradiated eyes compared to placebo eyes.47 Fried- 
man et al have also investigated beta irradiation in 
an animal model of GFS.@ In one experiment, a 
single 2500 rad dose of focal beta irradiation applied 
24 hours before perform&g posterior lip sclerecto- 
mies in six rabbit eyes produced no difference in 
bleb survival and histologic appearance, as com- 
pared to operated eyes that did not receive adjuvant 
irradiation. In a second experiment, each of live 
eyes oftive rabbits was given three 2000 rad doses of 
beta irradiation - one to four days preoperatively, 
immediately before surgery, and one to three days 
postoperatively. 4* Fellow eyes that were operated 
without preoperative or postoperative irradiation 
routinely developed bleb scarring in two to three 
weeks. In contrast, treated eyes demonstrated clini- 
cally functional blebs. Histologic evaluation indi- 
cated that the treated eyes had substantially less 
granulation tissue at the sclerectomy sites than the 
nonirradiated surgical sites. 
Tissue culture studies suggested that beta irra- 
diation may inhibit libroblast proliferation at rad 
doses not previously associated with conjunctival”’ 
and sclera12*~7g~‘90~‘8’ necrosis and lenticular opac- 
ities.72J8’ However, these complications may occur 
with 2000 rad doses of beta irradiation,‘80$‘8’ which 
are less than the total doses used to achieve func- 
tional blebs in a preliminary animal study48 and one 
clinical study. 27 The therapeutic efficacy and poten- 
tial complications of beta irradiation in conjunction 
with GFS remain to be defined. 
6. Implants in Glaucoma Filtering Surgery 
To enhance the GFS success rates in eyes with 
neovascular glaucoma and other glaucomas with 
poor surgical prognoses, a variety of modified filter- 
ing procedures with implants for aqueous drainage 
have been introduced. The most widely used drain- 
age implants include the Denver-Krupin valve,g0,‘7g 
the anterior chamber tube shunt to an encircling 
band (ACTSEB),‘55 and the Molten0 im- 
plant. 22~‘2~‘24 As discussion of these implants is out- 
side the scope of this wound healing review, interest- 
ed readers are referred to the references 
cited 124a,l55a,l55b 
B. PHARMACOLOGIC MODULATION 
OF WOUND HEALING 
1. Corticosteroids 
Postoperative corticosteroids have been widely 
used since Sugar described their apparent effects on 
filtration blebs.“’ Their efficacy presumably results 
from inhibition of the inflammatory response,38*“4,*g6 
direct effects on fibroblasts and connective tissue,52 
and inhibition of fibroblast proliferation.‘g~38~“4 Spe- 
cific antiinflammatory effects include suppression of 
fibrin deposition, capillary permeability, migration 
of leukocytes and macrophages, and phagocytic ac- 
tivity. 5g,60~‘30 The inhibition of fibroblast prolifera- 
tion by corticosteroids may be dose-dependent, as 
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FQ. 10. Thin cystic filtering bleb 16 weeks after posterior 
lip sclerectomy in owl monkey treated with postoperative 
subconjunctival 5-FU. (Reprinted with permission from: 
Gressel MG, Parrish RK II, Folberg R: 5-fluorouracil 
and glaucoma filtering surgery: 1. An animal model. Oph- 
thalmology 91:378-383, 1984.) 
Fig. II. Scarred conjunctiva at surgical site in control owl 
monkey eye 16 weeks after surgery. (Reprinted with per- 
mission from: Gressel MG, Parrish RK II, Folberg R: 5- 
fluorouracil and glaucoma filtering surgery: 1. An animal 
model. Ophthalmology 91:378-383, 1984.) 
tissue culture studies have shown an increase in the 
replication rate of fibroblasts at low concentrations 
but an inhibitory effect at high concentrations.lg 
Corticosteroids produce a similar biphasic effect on 
protein and DNA synthesis by human subconjunc- 
tival fibroblasts in tissue cu1ture.s 
In a controlled trial to evaluate the clinical eflica- 
cy of postoperative corticosteroids in GFS, Starita et 
al reported a 96% success rate (stabilization of IOP, 
visual field, and optic nerve) in 25 eyes that received 
topical prednisolone acetate 1% compared to 76% 
success in 21 eyes that did not receive topical corti- 
costeroids (p < .05, analysis of variance) .‘74 System- 
ic prednisone given in addition to topical cortico- 
steroids to 22 patients did not significantly improve 
success rates. Although eyes that received corticos- 
teroids appeared to have thinner, more cystic blebs 
than eyes that did not receive corticosteroids, this 
observation was not statistically significant. The use 
of preoperative corticosteroids has also been advo- 
cated. Simmons has suggested initiation of both 
topical and systemic corticosteroids prior to surgery 
to blunt the inflammatory response.‘64 
Many surgeons inject corticosteroids subconjunc- 
tivally after surgery, though these injections usually 
are not administered at the surgical site. Giangia- 
coma et al have proposed that preoperative subcon- 
junctival corticosteroids injected directly at the fil- 
tering site may be beneficial.5’ In each of 15 eyes at 
high risk for postoperative bleb failure, a 4 mg sub- 
conjunctival injection of a long-acting depot corti- 
costeroid, triamcinolone acetonide, was adminis- 
tered at the surgical site one week preoperatively in 
12 eyes, two days prior to surgery in one eye, and the 
day ofsurgery in two eyes. With a mean follow-up of 
11.7 months, 14 of 15 eyes had intraocular pressures 
of 5 18 mm Hg and diffuse microcystic blebs. No 
significant complications occurred in this pilot se- 
ries, although cases of poor wound healing around 
the injection tracts and severe thinning or melting of 
the conjunctiva over the drug site have since been 
reported .53,1g4a The authors attributed the encourag- 
ing preliminary results to a localized cytocidal effect 
of the corticosteroid on adjacent fibroblasts, induc- 
tion and lysis of macrophages, and alteration of col- 
lagen fibers in the vicinity of the injection in both 
humans and rabbits.52 They speculated that the re- 
lease of potent degradative enzymes from lysed ma- 
crophages may account for some of the tissue effects. 
In contrast, Ball described an increased libro- 
blast response in and around 8 mg subconjunctival 
injections of triamcinolone acetonide in rabbits.’ He 
also reported dense fibrous reactions around 12 mg 
injections of the depot drug in three patients who 
subsequently underwent surgical bleb revisions. It 
is not known whether these contrasting observa- 
tions are related to higher triamcinolone dosages, 
variations in surgical technique, or other factors.53 
While the preliminary results of preoperative sub- 
conjunctival corticosteroids are encouraging, the 
need for a controlled clinic trial has been stressed by 
the authors.5’,j2 
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Fig. 22. Histology of 5-FU treated 
owl monkey eye, showing patent 
sclerectomy, basal iridectomy, and 
filtering bleb (hematoxylin-eosin, 
X 10). (Reprinted with permission 
from: Gressel MG, Parrish RK II, 
Folberg R: 5-fluorouracil and glau- 
coma filtering surgery: 1. An animal 
model. Ophthalmology 91:378-383, 
1984.) 
Fig. 13. Histology of control owl 
monkey eye. Basal iridectomy is 
present. Fibrovascular connective 
tissue bridges surgical site. No bleb 
is present (periodic acid-Schiff, 
X 10). (Reprinted with permission 
from: Gressel MG, Parrish RK II, 
Folberg R: 5-fluorouracil and glau- 
coma filtering surgery: 1. An animal 




Recently, 5-fluorouracil (5-FU), a pyrimidine 
analog with antimetabolic activity, has gained at- 
tention as an adjuvant to GFS. This agent inhibits 
fibroblast proliferation in tissue culturelg and is be- 
lieved to reduce postoperative scarring by decreas- 
ing libroblast proliferation.57@ Gressel et al de- 
scribed filtering blebs after four months in six of 
eight owl monkey eyes which received subconjuncti- 
val 5-FU and bleb failure in all control eyes within 
two weeks postoperatively (Figs. 10-13).57 
In a pilot study of postoperative subconjunctival 
5-FU, Heuer et al reported increased success rates 
of GFS in high-risk patients with aphakia, neovas- 
cular glaucoma, or previously failed surgery.68a70 
They defined success as intraocular pressure 5 2 1 
mm Hg with or without ocular hypotensive medica- 
tions or 22-25 mm Hg without medications, with no 
further glaucoma surgical procedures. Successful 
results were reported in 68% of 48 aphakic eyes, 
81% of 16 eyes with previously failed GFS, and 75% 
of 16 eyes with neovascular glaucoma.70 In a life- 
table analysis of GFS in 88 aphakic eyes, 39 eyes 
with previously failed GFS, and 28 eyes with neo- 
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vascular glaucoma, success rates at two years were 
63%) 75%) and 68%) respectively.14g Additional 
studies of postoperative subconjunctival 5-FU have 
also reported enhanced success in eyes at high risk 
for surgical failure.‘5’a,‘*ga 
As a result of the antiproliferative effects of 5-FU, 
its administration is commonly associated with the 
development of conjunctival and cornea1 epithelial 
defects and conjunctival wound and suture tract 
leaks 68,70,‘49 
In’addition, severe cornea1 complications includ- 
ing bacterial cornea1 ulceration, sterile cornea1 ul- 
ceration, and development of a keratinized cornea1 
plaque with an underlying sterile stromal infiltrate 
have recently been described in patients with preex- 
isting cornea1 abnormalities who received postoper- 
ative 5-fluorouracil.84 Although success rates of GFS 
with subconjunctival 5-FU compare favorably with 
results in previous series of high risk patients, a 
clinical trial sponsored by the National Eye Insti- 
tute is currently underway to evaluate the safety and 
efficacy of subconjunctivally injected 5-FU in apha- 
kit or pseudophakic eyes and in those with prior 
unsuccessful GFS. 
Since topical 5-FU would be more convenient 
than subconjunctival injections, the efficacy of this 
method of drug delivery has been evaluated in ani- 
mal models. Pharmacokinetic studies in normal 
rabbit eyes showed that topically applied 5-FU 
achieved sufficient levels in the ocular compart- 
ments and tissues to have potential therapeutic ap- 
plications. 42 Topical administration of 5-FU after 
posterior lip sclerectomies in owl monkeys produced 
delayed bleb scarring.7’ Seven of nine eyes de- 
veloped cornea1 epithelial defects during topi- 
cal therapy, and two corneas became opacified. 
The authors concluded that topical 5-FU may be 
more toxic to the cornea than subconjunctival 
administration. 
b. Other Antimetabolites 
While 5-fluorouracil has received the most atten- 
tion in conjunction with GFS, other antimetabolic 
agents have also been studied. Trifluorothymi- 
dine,14’ doxorubicin hydrochloride,lg daunarubi- 
tin,‘” bleomycin,g2~gg and cytarabine (ara-C)g2~ggJ02 
inhibited proliferation of tibroblasts in tissue cul- 
ture. Although cytarabine has not been used in con- 
junction with GFS, one potential advantage is the 
blockage of cytarabine-related ocular toxic effects 
by supplemental 2’-deoxycytidine.102 Bleomycin in- 
corporated in a collagen polymer sponge was re- 
ported to enhance bleb survival in a rabbit mode1.82 
Fluoropyrimidine analogs other than 5-fluorour- 
acil have also demonstrated antiproliferative activ- 
ity when tested in tissue culture.20J’ Fluorouridine 
and its monophosphate2’ were 50 to 100 times more 
potent than 5-fluorouracil on a weight/weight basis. 
Both 5’ fluorouridine 5’-monophosphate”j7 and 5- 
fluoroorotate,54,6’,6’a another fluoropyrimidine, have 
been encapsulated in liposomes and tested in pri- 
mate models of GFS (VIII. A. 1). 
3. Inhibitors of Collagen Cross-linking 
In the biosynthesis of collagen, procollagen is 
formed intracellularly by tibroblasts and is then se- 
creted into the extracellular space, where the pro- 
collagen undergoes biochemical transformation into 
tropocollagen. lg2 The tropocollagen molecules then 
aggregate into immature soluble collagen fibrils, 
which, in turn, undergo cross-linking to form ma- 
ture collagen with greater tensile strength. 
Beta-aminopropionitrile (BAPN) and D-penicil- 
lamine, which inhibit collagen cross-linking and 
maintain a state of uncross-linked immature colla- 
gen, ‘33 have received attention as potential adjuncts 
to reduce ocular scarring. Moorhead described (1) a 
significant effect of topical BAPN ointment in limit- 
ing contracture of the fornices after conjunctival al- 
kali injuries in rabbits;lz5 (2) decreased posttrau- 
matic vitreous proliferation in rabbits after both 
topical and systemic BAPN;lz6 and (3) the possible 
effectiveness of BAPN in enhancing longterm com- 
pliance and reducing refractive regression after ra- 
dial keratotomy. lz7 The latter findings have been 
disputed by Busin et a1.24 
On the premise that BAPN may decrease the ten- 
sile strength of the scar at the filtering site and en- 
hance the development of a functional bleb, topical 
BAPN ointment was administered for three months 
after GFS to each of 23 patients with aphakia, neo- 
vascular or uveitic glaucoma, or previously failed 
GFS.12* An overall success rate (IOP 121 mm Hg 
with or without medications) of 74% was reported 
with a mean follow-up of 26.4 + 11 weeks. 
D-penicillamine, a copper chelator frequently 
used to treat Wilson’s disease, is another lathyro- 
genie agent which acts at a different site than BAPN 
to prevent collagen cross-linking.‘33 (BAPN inhibits 
lysyl oxidase and prevents formation of aldol con- 
densation side chains. D-penicillamine prevents 
cross-linking by chelating lysyl-derived aldehyde 
condensation bonds after they have formed.‘33) D- 
penicillamine has been reported to decrease colla- 
gen synthesis by subconjunctival tibroblasts.“’ In a 
rabbit model, subconjunctival injections of D-peni- 
cillamine prolonged the duration of bleb function 
after GFS;“2a however, the use of D-penicillamine 
after GFS in humans has not been reported. 
McGuigan et al have performed animal studies in 
which cynomolgus monkeys with laser-induced 
glaucoma underwent punch sclerectomies followed 
164 Surv Ophthalmol 32(3) November-December 1987 SKUTA AND PARRISH 
by adjunctive therapy with BAPN or penicilla- 
mine.‘ub Eyes treated with these agents maintained 
successful filtration for at least three days longer 
than control eyes, which received no drug treat- 
ment. The authors speculated that the lack of more 
prolonged effect on the patency of the sclerectomies 
could be explained by inadequate effective drug 
concentration or a biochemical action which affects 
only a minor portion of the healing process. 
BAPN and D-penicillamine received attention as 
possible adjuvants due to their use in the treatment 
of keloids’34 and urethral strictures.‘35 Although 
their inhibition of mature extracellular matrix pro- 
duction and the possible effects of post-GFS wound 
healing are of considerable interest, more definitive 
basic and clinical investigations will be necessary if 
the potential of these agents for use after GFS is to 
be determined. Currently, a multicenter random- 
ized clinical trial is underway to investigate topical 
BAPN after reoperation in phakic eyes with pre- 
viously failed glaucoma filtering surgery. 
VIII, Future Directions 
A. MORE EFFECTIVE DRUG DELIVERY 
More effective drug delivery could be beneficial in 
improving surgical success rates after GFS. As not- 
ed, Giangiacomo et al recommended preoperative 
injection of corticosteroid depots at the operative 
site.5’ Sustained delivery systems of antimetabolites 
have also been described to provide (1) a reduction 
in peak drug levels and a more sustained release of 
drug; (2) a more convenient administration of anti- 
metabolite therapy, which currently often requires 
frequent subconjunctival injections;68,70p’4g and (3) a 
possible reduction in associated adverse effects. Sus- 
tained drug delivery from liposomes44,‘65,‘67 and slow 
release from bioerodable polymersg4 and mem- 
branesla are being evaluated. 
1. Liposomes 
Liposomes are synthetic membrane-like vesicles 
consisting of phospholipid bilayers which alternate 
with aqueous compartmentsg5 Depending on the 
solubility properties, a drug can be encapsulated in 
the lipid bilayer or trapped in the aqueous compart- 
ment. The drug may then be slowly released as the 
vesicles are broken down to achieve sustained drug 
delivery. 
Subconjunctivally injected liposomal 5-fluorour- 
acil in rabbits has provided sustained delivery of 5- 
fluorouracil.44j’65 Pharmacokinetic studies of cytara- 
bine entrapped in multivesicular liposomes have 
also been performed. Assil and Weinreb adminis- 
tered 6 mg of subconjunctival cytarabine to 12 rab- 
bits and reported that the tissue half-life of drug at 
the injection site was 52.5 hours in the six rabbits 
treated with liposomal cytarabine compared to 0.2 
hours in the six control animals treated with the 
same amount of drug in normal saline solution.4 
Liposomal cytarabine and 5-fluorouracil have not 
yet been studied in animal models of GFS. Sub- 
conjunctival administration of other liposomally 
encapsulated fluoropyrimidines, including 5-fluor- 
ouridine 5’-monophosphate (5-FUMP)‘67 and 5- 
fluoroorotate,54 at the filtering site have enhanced 
duration of sclerectomy patency and bleb survival 
in primate models. Bone marrow aplasia in one ani- 
mal and serious cornea1 complications in another 
animal were observed in the preliminary study of 
liposomal 5-FUMP, in which relatively high doses 
of the drug were used. ‘67 It is possible that lower 
doses may still inhibit wound healing and avoid 
these adverse effects. 
Winter et al have described histologically acute 
and chronic inflammatory changes in rabbits after 
subconjunctival injection of liposomes with and 
without 5-fluorouracil.‘g5 An initial predominance 
of eosinophils at four hours after the injections was 
followed by a shift to neutrophils by 24 hours and to 
lymphocytes and plasma cells by 48 hours. At one 
week, macrophages infiltration, fibroblast prolifera- 
tion, and angiogenesis were noted. The chronic in- 
filtrate had decreased around the injection site after 
two weeks. It is not yet known whether this type of 
response occurs with liposomal preparations other 
than those used by Winter et al. 
The relative importance of this potential inflam- 
matory response associated with liposomes’g5 must 
be evaluated in the context of the sustained fibro- 
blast inhibition that antimetabolites in a liposomal 
system may produce. In addition, the commercial 
feasibility of developing methods for the manufac- 
ture of stable and sterilizable liposomal prepara- 
tions may be a determinant in their future avail- 
ability.g5J4’ 
2. Polymers and Membranes 
Lee et al studied a slow release biodegradable 
polymer [ bis( p-carboxyphenoxy) hexane and seba- 
tic acid] containing 5-fluorouracil which was used 
as a seton after posterior lip sclerectomies in rab- 
bits.g4 In eyes that received polymer setons with 
10% 5-FU, lower mean intraocular pressures were 
maintained in the period to “double failure” (return 
of IOP to within two mm Hg of the preoperative 
starting pressure) as compared to eyes which did 
not receive 5-FU. However, the effect of 5-FU on 
prolonging time to failure was not statistically 
significant. 
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Fig. 14. Diagram of proposed inhibitory mechanisms of 
pharmacologic therapies at different stages of wound 
healing after glaucoma filtering surgery. 
Polyvinyl alcohol membranes which permit lin- 
ear release rates of 2 1.7 mg/hr/mm* of membrane 
have also been designed for sustained 5-FU admin- 
istration.“j8 Pharmacokinetic and efftcacy studies in 
animals have not been reported with this system. 
Although investigation of sustained release sys- 
tems for antimetabolites in GFS remains prelimi- 
nary, the concept of controlled release to maximize 
the therapeutic effect and minimize relative toxicity 
is appealing. 
3. Combination Drug Therapy 
Combinations of pharmacologic modalities that 
affect different steps in the wound healing process, 
much like combination chemotherapy, could theo- 
retically improve GFS success and minimize toxic 
effects. Corticosteroids, which decrease the inflam- 
matory response38,5g,60,“4,‘g6 and diminish release of 
plasma proteins and formation of the fibrin-fibro- 
nectin matrix early in the postoperative course, may 
reduce stimuli for fibroblast proliferation. As noted 
previously, high doses of corticosteroids may also 
have direct effects on libroblasts and fibroblast 
proliferation.8~‘g~52 
Fibroblast proliferation, which becomes particu- 
larly important approximately five days postopera- 
tively,34,‘58 can also be inhibited by antimetabolite 
therapy. ‘%*’ Thus, topical corticosteroids, in com- 
bination with antimetabolite therapy, could be ad- 
ditive in inhibition of wound healing. Current 
regimens of subconjunctival 5-fluorouracil ther- 
apy also include intensive topical corticosteroid 
treatment.68~70~‘4g 
Blockage of collagen cross-linking by BAPN or D- 
penicillamine or both is an additional step of wound 
healing which could be inhibited by combination 
therapy. These agents could maintain secreted col- 
lagen in a more soluble immature state during topi- 
cal treatment.‘28 Collagen which has failed to cross- 
link because of lathyrogenic therapy will remain 
uncross-linked.‘33 However, once this treatment is 
discontinued, collagen cross-linking of newly syn- 
thesized collagen would occur. At what point ad- 
ministration and discontinuation of lathyrogenic 
treatment would be appropriate is not known. 
Attacking the wound healing process at multiple 
sites after GFS has considerable merit. How cur- 
rently studied agents may affect wound healing is 
summarized in Fig. 14. It is likely that only through 
carefully controlled clinical trials will the efficacy 
and optimal timing of such therapy be established. 
B. SURGICAL INNOVATION 
Surgical modifications of conventional tech- 
niques and new applications of laser technology 
may provide areas for future development. Brown et 
al described an automated trephine which may be 
introduced across the anterior chamber to perform a 
full thickness sclerectomy ab interno. They pro- 
pose that this method could provide access to fil- 
tering sites not easily accessible by conventional 
techniques, decrease surgical manipulation of con- 
junctival and episceral tissue, and reduce problems 
with wound and suture tract leaks associated with 
antimetabolite therapy. 
Beckman et al first described the use of carbon 
dioxide lasers during GFS for creation of ab externo 
limbectomies in the early 197Os.‘O More recently, ab 
interno full thickness sclerostomies and filtering 
blebs have been created with the neodymium-YAG 
laser using a gonioscopy lens in a living human 
eye, lo5 human eye bank eyes,‘03 and the eyes of rab- 
bits’” and nonhuman primates.50,‘04 With the use of 
fiberoptic systems introduced across the anterior 
chamber, ab interno sclerostomies have also been 
performed in enucleated human and bovine eyes 
with continuous wave ultraviolet and visible blue 
radiation from an argon laser,4g,8’ and in monkey 
eyes with a pulsed dye laser.g3 Scleral ablation with 
the excimer laser has been described’6aJ44 and may 
also be possible with the hydrogen fluoride laser.‘” 
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Ab interno laser sclerostomies could potentially re- 
duce operative manipulation of the conjunctiva, 
and perhaps reduce the associated inflammatory 
and fibroproliferative responses. 
C. BETTER UNDERSTANDING OF WOUND 
HEALING 
Further understanding of wound healing after 
glaucoma filtering surgery will require a more pre- 
cise delineation of the physiological and biochemi- 
cal factors that affect early as well as late bleb fail- 
ure. Identification of these factors may be possible 
by the application of information derived from other 
medical and surgical disciplines as well as by further 
ophthalmologic research. The considerable re- 
search effort in the cell biology of proliferative vi- 
treoretinopathy may provide additional insight into 
wound healing after GFS. This information, in turn, 
may permit modulation of wound healing with 
minimization of potential adverse effects seen with 
current agents. 
IX. Conclusions 
Wound healing after glaucoma filtering surgery 
depends on a wide variety of clinical, physiologic, 
surgical, and pharmacologic factors that may affect 
surgical success. We cannot predict which of the 
newer methods will prove to be most successful. 
However, a more complete knowledge of the princi- 
ples of wound healing and new information derived 
from well controlled basic and clinical studies will 
enable us to better assess the safety and efficacy of 
current and future therapies. 
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